✨ Free AI Report
Patheon: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Company Research

Patheon: Business Overview, Financials & Competitive Analysis

Patheon operates as a Global CDMO providing integrated drug development, clinical trials, and manufacturing services. Acquired by Thermo Fisher Scientific, Patheon is one of the industry's most widely recognized contr...

Analyst-debate audio for Patheon

AskCyborg analysts argue the bull and bear cases for Patheon across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
8/ 10Strong

Cyborg Score thesis

Leading CDMO with diversified service offerings and global footprint, strengthened by Thermo Fisher ownership and positioned for...

Read the full analyst-debate transcript →
Industry Pharmaceuticals
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 16, 2026
AI-Generated Research
30+ Page Report

Get the Latest Patheon Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Patheon Overview

Pro stress-test →

Patheon operates as a Global CDMO providing integrated drug development, clinical trials, and manufacturing services. Acquired by Thermo Fisher Scientific, Patheon is one of the industry's most widely recognized contract development and manufacturing organizations (CDMOs) with more than 60 locations worldwide.

Strategic Profile

Pro stress-test →

The company offers comprehensive contract development and manufacturing organization (CDMO) and contract research organization (CRO) solutions to accelerate drug development journeys. Their capabilities span small and large molecules, advanced therapies like viral vectors, cell therapy, and mRNA, and steriles. Patheon delivers complete end-to-end CDMO capabilities for small molecules, large molecules, advanced therapies, clinical trials, and commercial services to help move from molecule to medicine to market.

Competitive Landscape

Pro stress-test →

Patheon's top competitors include companies like Anthem Biosciences, KBI Biopharma and Abingdon Health. Patheon competes in the CDMO market as a diversified, integrated provider with capabilities across small molecules, biologics, and advanced therapies. Its scale (60+ global facilities, 8,400+ staff) and Thermo Fisher backing differentiate it from mid-sized competitors.

Industry Context

Patheon operates in Pharmaceuticals.

Key facts

Founded: 1974 · Headquarters: Durham, North Carolina, US · Employees: 8,400+ · Revenue: $1.9B (2016 pre-acquisition) · Market cap: N/A

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Patheon.

  • Patheon was acquired in August 2017 by Thermo Fisher for $7.2 billion.
  • Patheon operates more than 60 locations worldwide with integrated, end-to-end solutions across all phases of development.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • June 2026Patheon participates in BIO 2026 conference (booth #5125) showcasing 360° CDMO and CRO solutions
  • October 2012Patheon acquired Banner Pharmacaps in High Point, North Carolina
  • +1 moreTrack every material event for Patheon as it happens. Explore monitoring →
Get alerted when Patheon has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Patheon with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Patheon operates in Pharmaceuticals. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals research →
NEW · MCP server

Ask your AI assistant about Patheon

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Patheon and its top competitor on Cyborg Score”
“What did Patheon do this quarter?”
“Is Patheon a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Patheon do?+
Patheon operates as a Global CDMO providing integrated drug development, clinical trials, and manufacturing services. Acquired by Thermo Fisher Scientific, Patheon is one of the industry's most widely recognized contr...
What is Patheon's Cyborg Score?+
Patheon has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Patheon's main competitors?+
Named competitors include Catalent CDMO Services, Lonza CDMO, KBI Biopharma, Anthem Biosciences. The full competitive landscape is in the AskCyborg report.
How can I get the full Patheon research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Patheon research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Patheon over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual